Consistent with MLL/AF6, the human MMP-2 and -9 transcriptions were initially detected at day 21 after being challenged by SHI-1 and amplified in all killed mice with CNS leukemia (Fig. 6A). The gene discussed is KMT2A; the disease is central nervous system leukemia.